EXOSC10
Basic information
Region (hg38): 1:11066618-11099869
Previous symbols: [ "PMSCL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOSC10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 43 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 43 | 2 | 1 |
Variants in EXOSC10
This is a list of pathogenic ClinVar variants found in the EXOSC10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-11066734-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
1-11068021-C-T | not specified | Uncertain significance (May 24, 2024) | ||
1-11068039-T-C | not specified | Uncertain significance (Nov 27, 2023) | ||
1-11068042-T-G | not specified | Uncertain significance (Aug 28, 2023) | ||
1-11068080-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
1-11068691-T-C | not specified | Uncertain significance (Jan 23, 2023) | ||
1-11069598-G-C | not specified | Uncertain significance (Apr 22, 2024) | ||
1-11070913-C-T | Likely benign (Apr 01, 2023) | |||
1-11070917-C-T | not specified | Uncertain significance (Jan 18, 2023) | ||
1-11070943-T-C | not specified | Uncertain significance (Oct 06, 2023) | ||
1-11072089-G-C | not specified | Uncertain significance (Apr 19, 2023) | ||
1-11073927-C-T | Likely benign (Feb 01, 2024) | |||
1-11073948-T-C | Likely benign (Jan 01, 2023) | |||
1-11073972-G-C | not specified | Uncertain significance (Oct 27, 2022) | ||
1-11073981-G-C | not specified | Uncertain significance (Mar 21, 2024) | ||
1-11074272-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
1-11076853-T-A | not specified | Uncertain significance (May 30, 2023) | ||
1-11077376-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
1-11077413-C-G | not specified | Uncertain significance (Jul 12, 2023) | ||
1-11077440-A-T | not specified | Uncertain significance (Jan 06, 2023) | ||
1-11077633-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
1-11079734-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
1-11079779-G-T | not specified | Uncertain significance (Feb 28, 2024) | ||
1-11080866-T-C | not specified | Uncertain significance (Dec 06, 2021) | ||
1-11081096-C-T | not specified | Uncertain significance (Aug 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EXOSC10 | protein_coding | protein_coding | ENST00000376936 | 25 | 33264 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.97e-14 | 0.999 | 125668 | 0 | 80 | 125748 | 0.000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.870 | 453 | 508 | 0.891 | 0.0000283 | 5840 |
Missense in Polyphen | 129 | 172.88 | 0.74617 | 2029 | ||
Synonymous | -0.0408 | 194 | 193 | 1.00 | 0.0000114 | 1644 |
Loss of Function | 3.19 | 32 | 58.3 | 0.549 | 0.00000321 | 619 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000782 | 0.000782 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000491 | 0.000489 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000283 | 0.000281 |
Middle Eastern | 0.000491 | 0.000489 |
South Asian | 0.000429 | 0.000425 |
Other | 0.000654 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. EXOSC10 has 3'-5' exonuclease activity (By similarity). EXOSC10 is required for nucleolar localization of C1D and probably mediates the association of MTREX, C1D and MPP6 wth the RNA exosome involved in the maturation of 5.8S rRNA. {ECO:0000250, ECO:0000269|PubMed:14527413, ECO:0000269|PubMed:16455498, ECO:0000269|PubMed:17412707, ECO:0000269|PubMed:17545563, ECO:0000269|PubMed:18172165, ECO:0000269|PubMed:19056938, ECO:0000269|PubMed:20368444, ECO:0000269|PubMed:20699273}.;
- Pathway
- RNA degradation - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.306
Intolerance Scores
- loftool
- 0.0801
- rvis_EVS
- -1.24
- rvis_percentile_EVS
- 5.49
Haploinsufficiency Scores
- pHI
- 0.377
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.963
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Exosc10
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of 5.8S rRNA;nuclear-transcribed mRNA catabolic process;rRNA processing;dosage compensation by inactivation of X chromosome;negative regulation of telomere maintenance via telomerase;nuclear mRNA surveillance;CUT catabolic process;nuclear polyadenylation-dependent rRNA catabolic process;histone mRNA catabolic process;nuclear retention of unspliced pre-mRNA at the site of transcription;RNA phosphodiester bond hydrolysis, exonucleolytic;regulation of telomerase RNA localization to Cajal body
- Cellular component
- nuclear exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;membrane;transcriptionally active chromatin
- Molecular function
- nucleotide binding;3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding;telomerase RNA binding